Cymabay Therapeu (CBAY) Insider Trading
- $5,607,476.95
- $26,069,658.72
- Feb. 12, 2024
- Kurt Von Emster
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 25, 2018 | Director | 39,438 | $12.18 | Sell | $480,354.84 | |
| Jan. 22, 2018 | Director | 138,253 | $10.40 | Sell | $1,437,831.20 | |
| Jan. 19, 2018 | Director | 144,216 | $10.25 | Sell | $1,478,214.00 | |
| Jan. 5, 2018 | Director | 4,300 | $10.21 | Sell | $43,903.00 | |
| Dec. 22, 2017 | Director | 173,192 | $9.41 | Sell | $1,629,736.72 | |
| Nov. 10, 2017 | Director | 50,048 | $9.26 | Sell | $463,444.48 | |
| Nov. 2, 2017 | Director | 18,000 | $8.66 | Sell | $155,880.00 | |
| Nov. 2, 2017 | SVP | 5,000 | $8.67 | Buy | $43,350.00 | |
| Oct. 31, 2017 | Director | 59,209 | $9.27 | Sell | $548,867.43 | |
| Oct. 3, 2017 | Director | 108,876 | $7.85 | Sell | $854,676.60 | |
| Sept. 29, 2017 | Director | 211,124 | $8.09 | Sell | $1,707,993.16 | |
| Aug. 1, 2017 | Director | 5,000 | $6.84 | Buy | $34,200.00 | |
| July 20, 2017 | Insider | 10,000 | $7.34 | Buy | $73,400.00 | |
| July 20, 2017 | SVP | 5,000 | $7.43 | Buy | $37,150.00 | |
| Sept. 6, 2016 | Director | 25,000 | $2.43 | Buy | $60,750.00 | |
| April 15, 2016 | VP | 3,000 | $1.68 | Buy | $5,040.00 | |
| April 5, 2016 | CFO | 55,000 | $1.39 | Buy | $76,450.00 | |
| April 4, 2016 | CFO | 22,000 | $1.39 | Buy | $30,580.00 | |
| Sept. 11, 2015 | Director | 46,729 | $2.74 | Sell | $128,037.46 | |
| Aug. 14, 2015 | Director | 90,000 | $2.69 | Buy | $242,100.00 | |
| July 20, 2015 | Director | 1,600,000 | $2.81 | Buy | $4,496,000.00 | |
| May 18, 2015 | CEO | 7,500 | $3.34 | Buy | $25,050.00 | |
| May 18, 2015 | CFO | 10,000 | $3.40 | Buy | $34,000.00 | |
| May 15, 2015 | VP | 2,000 | $3.16 | Buy | $6,320.00 |
Insiders are both buying and selling Cymabay Therapeu stock.
The insider traders at Cymabay Therapeu are: Kurt Von Emster, Sujal Shah, Charles Mcwherter, Paul T. Quinlan, Dennis D Kim, Daniel Menold, Carl Goldfischer, Janet Dorling, Robert James Wills, Emster Kurt Von, and Wart Harold Van
The most active insider trader at Cymabay Therapeu is Kurt Von Emster with 18 trades.
Kurt Von Emster has sold the most Cymabay Therapeu stock with a total value of $16,971,100.71.
Emster Kurt Von has bought the most Cymabay Therapeu stock with a total value of $4,980,200.00.
The most recent insider trade for Cymabay Therapeu was on Feb. 12, 2024.
The single biggest insider buy for Cymabay Therapeu was from Emster Kurt Von with a total value of $4,496,000.00 on July 20, 2015.
The single biggest insider sell for Cymabay Therapeu was from Kurt Von Emster with a total value of $3,464,925.73 on Feb. 14, 2018.